NIH Funding · FY2024
Total Funding
$5.2M
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#1,036
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $5.2M across 1 grant · National rank #1036.
Top grants by award amount
Matthew W Kalnik's NIH grant portfolio, ranked by award amount.
- 5U01DA058547-02U01IND-enabling Studies in Support of First in Human Safety Studies of a Novel Anti-Nicotine Human Monoclonal Antibody$5.2Maward amount
Affiliation
Institutions that have administered grants for Matthew W Kalnik.
Affiliated with Antidote Therapeutics, Inc. (MD).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardAntidote Therapeutics, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1036
- 2024Entered Top 25% NationallyRanked #1036
- 2024Entered Top 10% NationallyRanked #1036
Explore further
Find collaborators for Matthew W Kalnik
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Antidote Therapeutics, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →